At the 3-month follow-up, thyroid hormone, GH, and insulin-like growth factor-1 (IGF-1) levels had normalized.<h4>Conclusions</h4>This case highlights Lugol's solution as a rescue therapy for SSA-insensitive TSH/GH co-secreting pituitary adenomas. The gene discussed is GH1; the disease is pituitary gland adenoma.